Nikko Synergy Partners
3
21M
2
0.33
2
- Areas of investment
Summary
The leading representative office of defined VC is situated in the Menlo Park. The company was established in North America in United States.
The typical case for the fund is to invest in rounds with 8 participants. Despite the Nikko Synergy Partners, startups are often financed by Vanguard Ventures, Medtronic, The Rahn Group. The meaningful sponsors for the fund in investment in the same round are Vanguard Ventures, The Rahn Group, RiverVest. In the next rounds fund is usually obtained by Vanguard Ventures, QuestMark Partners, Medtronic.
Besides, a startup needs to be aged 2-3 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline Salient Surgical Technologies, Medivance The fund has specific favorite in a number of founders of portfolio startups. Among the most popular fund investment industries, there are Hospital, Medical. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.
Comparing to the other companies, this Nikko Synergy Partners performs on 38 percentage points more the average number of lead investments. The fund is constantly included in less than 2 investment rounds annually. The important activity for fund was in 2001. The top amount of exits for fund were in 2011. The usual things for fund are deals in the range of 10 - 50 millions dollars.
Investments analytics
Analytics
- Total investments
- 3
- Lead investments
- 0
- Exits
- 2
- Follow on index
- 0.33
- Investments by industry
- Biotechnology (3)
- Medical (2)
- Marketing (2)
- Health Care (2)
- Manufacturing (1) Show 1 more
- Investments by region
-
- United States (3)
- Peak activity year
- 2000
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 23
- Avg. valuation at time of investment
- 387M
- Group Appearance index
- 1.00
- Avg. company exit year
- 12
- Avg. multiplicator
- 4.46
- Strategy success index
- 0.67
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Medivance | 18 Jun 2001 | Biotechnology, Hospital, Manufacturing | Early Stage Venture | 16M | United States, Colorado |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.